Graviton BioScience

New York, NY · Founded 2020 · Privately Held (backing)

Developer of clinical-stage drugs designed for the treatment of autoimmune, cancer, and other serious diseases. Graviton BioScience is based in New York, NY and was founded in 2020. It was valued at $264 million at its early-stage round in Feb 2024, the last priced event on record. It has raised $93.3 million across 4 recorded rounds; the latest was a $25 million early-stage round in Jan 2024.

PMV mark · valuation
$264.0M
Oct 2026
Priced at
its early-stage round
Feb 2024
Total raised
$93.3M
Last round
Early Stage VC
Jan 2024

Who backs Graviton BioScience?

6 investors
InvestorType
Cormorant Asset ManagementVenture capital
Innova Capital PartnersGrowth equity
Deep FutureVenture capital
Enavate Sciences—
Ovid Therapeutics—
Pontifax Venture Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Graviton BioScience investors

6 investors are on record for Graviton BioScience, including Cormorant Asset Management, Innova Capital Partners, Deep Future and Enavate Sciences. The early-stage round in Jan 2024 drew 1 investor.

Free account
More of Graviton BioScience with a free account
  • ·Watch Graviton BioScience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Graviton BioScience. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View